Filing Flows › Health Catalyst (HCAT) › Q3 2026 › vs Q2 2026
Health Catalyst (HCAT) Q3 2026 vs Q2 2026 (quarter over quarter)
Health Catalyst's revenue fell $14.2M (-20%) from $70.5M in Q2 2026 to $56.3M in Q3 2026. The biggest changes: Technology −$8.1M (-17%); Accumulated Impairment Losses −$6.1M (-28%). Operating margin 89.1% against -51.8% (+140.8 pts).
Health Catalyst, Q3 2026: revenue $56.3M (-26% year over year), operating margin 89.1%, net earnings $40.5M, operating cash flow −$1.9M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 89.1% | -51.8% | +140.8 pts |
| Net margin | 72.0% | -57.5% | +129.5 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Technology | $40.7M | $48.8M | −$8.1M | -17% |
| Accumulated Impairment Losses | $15.6M | $21.7M | −$6.1M | -28% |
| Revenue | $56.3M | $70.5M | −$14.2M | -20% |
| Operating profit | $50.1M | −$36.5M | $86.6M | — |
| Costs & expenses | $6.1M | $107M | −$101M | -94% |
| Pre-tax earnings | $40.1M | −$40.2M | $80.3M | — |
| Other expense, net | $10.0M | $3.7M | $6.3M | +168% |
| Income tax benefit | $393K | −$315K | $708K | — |
| Net earnings | $40.5M | −$40.5M | $81.0M | — |
| Operating cash sources | $56.2M | −$27.1M | $83.3M | — |
| Depreciation & amortization | $9.7M | $11.0M | −$1.3M | -11% |
| Share-based compensation | $4.1M | $2.7M | $1.4M | +50% |
| Cash used in operations | $1.9M | −$275K | $2.1M | — |
| Working capital & other | $56.2M | −$27.1M | $83.3M | — |
Questions
How much did Health Catalyst's revenue grow quarter over quarter in Q3 2026?
Health Catalyst's revenue fell $14.2M (-20%) from $70.5M in Q2 2026 to $56.3M in Q3 2026.
What drove Health Catalyst's revenue change in Q3 2026?
Technology −$8.1M (-17%); Accumulated Impairment Losses −$6.1M (-28%).